Friends of Cancer Research Annual Meeting 2020: Day 1
Modernizing Expedited Development Programs
November 13, 2020
12:00PM EST - 1:00PM EST
Friends of Cancer Research (Friends) is proud to host our 13th Annual Meeting to address critical issues in the development of new oncology drugs. Each meeting brings together leaders from federal health and regulatory agencies, academic research, the private sector, and patient advocates to propose unique approaches toward current challenges in drug development.
We are excited to be hosting our 8th Virtual Meeting in 2020. Please register above and check below for the current draft agendas.
For information pertaining to Day 2 of the Annual Meeting, click here.
Day 1 | Modernizing Expedited Development Programs
Friday, November 13, 2020 | 12:00-1:00pm ET
12:00 PM Welcoming Remarks
- Ellen Sigal, Friends of Cancer Research
12:05 PM Keynote Address
- Stephen Hahn, Commissioner, FDA
12:10 PM Fireside Chat
- Richard Pazdur, Director, Oncology Center of Excellence, FDA
- Ellen Sigal, Founder & Chair, Friends of Cancer Research
12:25 PM Session 1: Modernizing Expedited Development Programs
Objective: This session will characterize current use and utility of expedited pathways in drug development and outline proposals for streamlining and enhancing their application for current drug development challenges and emerging complex therapies.
12:58 PM Closing remarks
- Jeff Allen, Friends of Cancer Research
1:00 PM Adjourn